CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$10,28
arrow_downward
-0,10%(-0,010) 1D
8 ກ.ລ., 16 ໂມງ 10 ນາທີ 21 ວິນາທີ GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$10,23
High
A$10,38
Low
A$10,00
Mkt. cap
໕໑໘,໔໐ ລ້ານ
Avg. vol.
໑໐໓,໖໖ ພັນ
Volume
໑໔໔,໗໔ ພັນ
Dividend
໐,໔໙%
Quarterly dividend
A$0,01
Ex-dividend date
4 ກ.ຍ. 2025
P/E ratio
໑໕,໙໖
52-wk high
A$14,00
52-wk low
A$8,35
EPS
A$0,64
Shares outstanding
໕໐,໔໓ ລ້ານ
No. of employees
໑໖
Open
A$10,23
High
A$10,38
Low
A$10,00
Mkt. cap
໕໑໘,໔໐ ລ້ານ
Avg. vol.
໑໐໓,໖໖ ພັນ
Volume
໑໔໔,໗໔ ພັນ
Dividend
໐,໔໙%
Quarterly dividend
A$0,01
Ex-dividend date
4 ກ.ຍ. 2025
P/E ratio
໑໕,໙໖
52-wk high
A$14,00
52-wk low
A$8,35
EPS
A$0,64
Shares outstanding
໕໐,໔໓ ລ້ານ
No. of employees
໑໖
News stories
From sources across the web
Stocks Down Under
·
18 ຊົ່ວໂມງກ່ອນ
Clinuvel Pharmaceuticals (ASX:CUV): Nearly 7 years on from the FDA's approval of Scenesse, this company is now at a crossroads
About Clinuvel Pharmaceuticals Ltd
AI content may include mistakes. Learn more